Glucagon-like Peptide-1 Receptor Agonists and Risk of Major Adverse Cardiovascular Events in Patients With CKD. Yau K, Ray JG, Jeyakumar N, Luo B, et al. Am J Kidney Dis 2026;87:211-229.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yau K, Ray JG, Jeyakumar N, Luo B, et al. Glucagon-like Peptide-1 Receptor Agonists and Risk of Major Adverse Cardiovascular Events in Patients With CKD. Am J Kidney Dis 2026;87:211-229.
PMID: 41238166